newsfilter
← Latest News
Business Wire·

Catalyst Launches New Multi-solution CRO Powered by the Medidata Rave Clinical Cloud™

NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) announced today that Catalyst Clinical Research chose the Medidata Rave Clinical Cloud™ for its one-platform approach to clinical trials. By adopting Medidata Rave CTMS combined with Rave EDC and Rave eTMF, Catalyst immediately offers a data-driven, state-of-the-art unified clinical platform as it launches its new CRO full-service managed solutions business in addition to its flagship resourcing and FSP businesses.